pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

37 catalysts · 3,045 8k filing · 571 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage · 89 approval

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: recall×from 2026-04-10×clear all
type
  • 8k filing3,045
  • earnings571
  • phase 2 completion172
  • grant138
  • drug shortage133
  • approval89
phase 1 completion
73
  • phase 2 initiation62
  • phase 1 initiation40
  • recall37
  • therapy area

    no tagged catalysts yet

    Week of Apr 6, 2026

    1
    ›04/10/2026recall123d agoVital Nutrient recall: Dietary Supplements

    Aller-C Dietary Supplement

    full page →fda recalls ↗

    Week of Apr 13, 2026

    34
    ›04/13/2026recall120d agoMorovan recall: Cosmetics

    Gel Nail Polish Remover (15ml)

    full page →fda recalls ↗
    ›04/14/2026recall119d agoGood Brain Tonic recall: Food & Beverages, Foodborne Illness, Carbonated Soft Drinks

    Good Brain Tonic 16 oz & 32 oz

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFagron Compounding Services recall (Cls II)Revalesio Corp

    Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-470-05, Unit of Sale NDC Number: 65219-470-30. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 63323-626-03, Unit of Sale NDC Number: 63323-626-25 (30 bags in 1 case). — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3509-04 carton, NDC 0591-3509-54 pouch — Reason: CGMP Deviations: use of an unapproved raw material — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20, Unit of Sale NDC Number: 65219-432-85. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 600047, Unit of Use NDC: 65219-468-05, Unit of Sale NDC Number: 65219-468-50. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-472-05, Unit of Sale NDC Number: 65219-472-20. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3508-04 carton, NDC 0591-3508-54 pouch — Reason: CGMP Deviations: use of an unapproved raw material — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFagron Compounding Services recall (Cls II)Revalesio Corp

    Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freeflex bag, Rx only, BD Beckton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-03. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoGE Healthcare Ireland Limited recall (Cls II)Amneal Pharmaceuticals, Inc.

    GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91. — Reason: Presence of particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC 69097-906-67 — Reason: Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch — Reason: CGMP Deviations: use of an unapproved raw material — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFagron Compounding Services recall (Cls II)Baxter Healthcare Corp

    norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freeflex bag, 1,000 mLx10, Fresenius Medical Care, Waltham, MA 02451, Distributed by: Fresenius Medical Care RTG, LLC, Manufactured by: Fresenius Kabi, Unit of Use NDC: 65219-282-01, Unit of Sale NDC Number: 65219-282-10. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoViatris, Inc. recall (Cls II)Viatris Inc

    Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91 — Reason: Failed Dissolution Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoPreferred Pharmaceuticals, Inc. recall (Cls II)InMed Pharmaceuticals Inc.

    Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFagron Compounding Services recall (Cls II)Baxter Healthcare Corp

    norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of Sale NDC Number: 65219-466-60. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-02. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFagron Compounding Services recall (Cls II)Revalesio Corp

    Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoGE Healthcare Ireland Limited recall (Cls II)Amneal Pharmaceuticals, Inc.

    GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63. — Reason: Presence of particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by Fresenius Kabi, Unit of Sale NDC Number: 17271-701-07. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall118d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67 — Reason: Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. — Status: Ongoing

    full page →fda recalls ↗
    ›04/16/2026recall117d agoLoard’s recall: Food & Beverages, Allergens, Ice Cream/Frozen Dairy

    Ice Cream

    full page →fda recalls ↗
    ›04/17/2026recall116d agoBreeder’s Edge, Shelter’s Choice recall: Animal & Veterinary, Food & Beverages

    Canine milk replacer

    full page →fda recalls ↗

    Week of Apr 20, 2026

    2
    ›04/20/2026recall113d agoAligned Medical Angio Pack recall: Medical Devices

    Angio Packs (AMS6908E and AMS6908F)

    full page →fda recalls ↗
    ›04/23/2026recall
    110d ago
    Frederik’s by Meijer recall: Food & Beverages, Allergens

    Vanilla Bourbon Trail Mix

    full page →fda recalls ↗
    $AMRX17.88-1.43%
    $TERN52.95-0.03%
    $TERN52.95-0.03%
    $TERN52.95-0.03%
    $AMRX17.88-1.43%
    $TERN52.95-0.03%
    $VTRS16.28-0.91%
    $INM1.4100-4.08%
    $TERN52.95-0.03%